Newsletter #18
November 4th, 2024

Dear all,

Plenty of news from our side and plenty of work as we prepare the big annual events of BioConvS who are coming in less than 4 weeks:

📅The BioConvS annual's symposium on November 28th > Innovation Day: Matchmaking

📅The first SynBioTherapy conference on November 27th

You might also be interested by our new grant call for postdoctoral fellowships which just opened last week. Let's get started with the news!

Innovation Day:
Matchmaking

👉find partners for collaborative projects
👉submit an abstract for a poster or a short talk
👉discover our platforms and funding opportunities
👉explore the ecosystem of BioConvS
👉meet Ile-de-France's tech transfer experts

DIM Events

SynBioTherapy

BioConvS and the PEPR Biothérapies organise a bridging event between their two annual symposiums to discuss about synergies between biotherapies and synthetic biology and to design the biotherapies of the future.

DIM calls

Our postdoc call is open
BioConvS will fund two 2-years postdoctoral positions on projects at the interface between synthetic biology and biotherapy.

Apply before January 31st!

Opportunities

Get free access to the ISCT Advanced Cell Therapy Manufacturing and Regulatory Course

A few individual yearly licenses are still available for of our Basic Lab Membership You can apply to access the ISCT network and training material, which notably includes the Advanced Cell Therapy Manufacturing and Regulatory Course, and much more!

Creative Destruction Lab
Bioconvergence stream

HEC and BioConvS are joining forces to launch CDL-BIOCONVERGENCE, an international-scale start-up accelerator in Île-de-France focused on health biotechnologies, to accelerate the transformation of scientific discoveries into innovations by leveraging the strengths of DIM BioConvS, reinforced by a proven international accelerator model, CDL.

1ere journée de l'Innovation en santé du pôle PSL Innovation
PSL University is organising its first Health Innovation Day by PSL Innovation Hub on November 19 at Institut Curie, focused on Biotherapies & Bioproduction. The event highlights academic-industry synergies, PSL’s scientific projects, medical expertise, and advanced technologies, with networking sessions and B2B meetings fostering collaboration.

Learn more about Biofoundries
What is a Biofoundry and why are we talking about it? Chiara wrote an article to help you understand the potential impact of this new way of doing research. Get inspired and start planning your research in the 4th industrial revolution!

The MEARY Center is recruiting a Production laboratory technician: Learn more

The Paris Biofoundry is recruiting the following positions: Engineer in Biological Analyses by Mass Spectrometry, Engineer in Software Development & Application Deployment.  Learn more

The startup Generare of this year's winner of the Innovation Prize Vincent Libis is recruiting the following positions: Biotechnology/Microbiology Technician, Natural Product Scientist (analytical chemistry & bioassays), Business Developer Learn more

Census of BioConvS labs
Starting January 2024, all labs affiliated or wanting to participate in a DIM BioConvS activity will have to be registered. Why? Most importantly because we want to build a cartography of biotherapy, bioproduction and synthetic biology in Ile-de-France and you want to make sure that you're on it!

Recent publications

Do you want to see your paper featured in our next newlsetter? Write to chiara.fracassi@u-paris.fr

Alexandre, L., Dubrova, A., Kunduru, A., Berger, M., Boucenna, I., Gazeau, F., Silva, A.K.A., Mangenot, S., Aubertin, K., 2024. In situ investigation of extracellular vesicles in viscous formulations: interplay of nanoparticle transport and nano rheology through interferometric light microscopy analysis. https://doi.org/10.1101/2024.04.12.589108

Das, S., Rruga, F., Montepeloso, A., Dimartino, A., Spadini, S., Corre, G., Patel, J., Cavalca, E., Ferro, F., Gatti, A., Milazzo, R., Galy, A., Politi, L.S., Rizzardi, G.P., Vallanti, G., Poletti, V., Biffi, A., 2024. An empowered, clinically viable hematopoietic stem cell gene therapy for the treatment of multisystemic mucopolysaccharidosis type II. Molecular Therapy 32, 619–636. https://doi.org/10.1016/j.ymthe.2024.01.034

Escribá, R., Beksac, M., Bennaceur-Griscelli, A., Glover, J.C., Koskela, S., Latsoudis, H., Querol, S., Alvarez-Palomo, B., 2024. Current Landscape of iPSC Haplobanks. Stem Cell Rev and Rep. https://doi.org/10.1007/s12015-024-10783-7

Nagle, I., Spek, L. van der, Gesenhues, P., Savy, T., Rea, L., Richert, A., Receveur, M., Delort, F., Batonnet-Pichon, S., Wilhelm, C., Luciani, N., Reffay, M., 2024. Mechanical constraints organize 3D tissues and orchestrate muscle differentiation. https://doi.org/10.1101/2024.10.03.616457

Raizada, G., Brunel, B., Guillouzouic, J., Aubertin, K., Shigeto, S., Nishigaki, Y., Lesniewska, E., Le Ferrec, E., Boireau, W., Elie-Caille, C., 2024. Raman spectroscopy of large extracellular vesicles derived from human microvascular endothelial cells to detect benzo[a]pyrene exposure. Anal Bioanal Chem. https://doi.org/10.1007/s00216-024-05567-4

Vloet, A.V. de, Prost-Boxoen, L., Bafort, Q., Paing, Y.T., Casteleyn, G., Jomat, L., Lemaire, S.D., Clerck, O.D., Peer, Y.V. de, 2024. Expanding the toolkit for ploidy manipulation in Chlamydomonas reinhardtii. https://doi.org/10.1101/2024.10.01.616035

Bredon, M., Danne, C., Pham, H.P., Ruffié, P., Bessede, A., Rolhion, N., Creusot, L., Brot, L., Alonso, I., Langella, P., Derosa, L., Cortot, A.B., Routy, B., Zitvogel, L., Segata, N., Sokol, H., 2024. Faecalibacterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors. OncoImmunology 13, 2374954. https://doi.org/10.1080/2162402X.2024.2374954

Ueda, N., Cahen, M., Leonard, J., Deleurme, L., Dreano, S., Sirac, C., Galy, A., Moreaux, J., Danger, Y., Cogné, M., 2024. Single-hit genome editing optimized for maturation in B cells redirects their specificity toward tumor antigens. Sci Rep 14, 22432. https://doi.org/10.1038/s41598-024-74005-3

Not on our list yet? Subscribe to the DIM Newsletter
Too many emails? Edit your preferences or unsubscribe from our list:

Pour vous désinscrire, cliquer ici